AI-generated summary
The authors retrospectively reviewed 14 patients with culture- or PCR-confirmed cutaneous Mycobacterium marinum infection treated with oral clarithromycin combined with red-light photobiomodulation and microwave therapy. They report clinical cure in 10 patients, marked improvement in 2 and partial improvement in 2, with no recurrence during follow-up of up to 36 months. The single-center, retrospective design limits the strength of these conclusions.
- Participants
- 14
- Who or what was studied
- Patients with culture- and/or nested PCR-confirmed cutaneous Mycobacterium marinum infection treated between 2021 and 2024 at a single center
- Limits stated in the abstract
- The study is a single-center retrospective review of 14 patients without a control group, so the findings cannot establish efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.